子宫肉瘤

  • 网络uterine sarcoma;sarcoma of uterus
子宫肉瘤子宫肉瘤
  1. 子宫肉瘤ADM阳性表达与核分裂相呈正相关,且预后差。

    In uterine sarcoma , ADM expression was positively correlated with mitotic activity , and poor prognosis .

  2. 应用COX模型对101例子宫肉瘤患者生存率影响因素的分析

    A Study on Factors Related to Survival in 101 Patients with Uterine Sarcoma by COX 'S Proportional Hazard Model

  3. 子宫肉瘤组织DNA含量和细胞增殖水平的测定及临床意义

    DNA Content and Cell Cycle Phase Analysis in Uterine Sarcomas and Its Clinical Significance

  4. 目的:研究凋亡调节蛋白bcl2及bax在子宫肉瘤和子宫肌瘤中的表达及意义。

    Objective To determine the expression and significance of the apoptosis regulatory protein bcl-2 and bax in uterine leiomyosarcomas and uterine leiomyomas .

  5. 结论IFO联合化疗是治疗复发或未控、特别是对PDD敏感的卵巢上皮癌、宫颈鳞癌以及子宫肉瘤的有效方案。

    Conclusion IFO combination chemotherapy is effective in treating recurrent or progressive gynecologic malignancies , especially PDD sensitive ones .

  6. 结论:对阳性表达CD117不可切除或转移性子宫肉瘤患者选择分子靶向治疗,提供理论依据。

    Conclusion : Theoretical foundation is laid for choice of molecularly-targeted therapy for CD117 positive in unresectable or metastatic uterine sarcomas .

  7. 目的:探讨钙结合蛋白S100A2、S100A4和ER、PR在子宫肉瘤中的表达及其相关性研究的临床意义。

    Objective : To investigate the expression of the S100A2 and S100A4 protein , ER and PR in sarcoma of uterus and evaluate its clinical significance .

  8. 以世界卫生组织1994年关于ESS的分类和国际抗癌协会(UICCAJCCS)对子宫肉瘤的分期为标准,进行分类和分期。

    The classification and stage were divided according to the standard of ESS which was set by WHO in 1994 and sarcoma of uterus which was set by UICC-AJCCS .

  9. 在ROC曲线上发现白细胞计数、中性粒细胞计数、NLR与子宫肉瘤的诊断相关(p0.01)。

    Receiver operating characteristic curve ( ROC curves ) shows the correlation between the leukocyte count , neutrophils count , neutrophils / lymphocytes ratio and the diagnosis of uterine sarcoma ( p 0.01 ) .

  10. 结果:S100A2和S100A4的表达与子宫肉瘤发生及预后有密切关系。

    Results : The expression of S100A2 and S100A4 protein was related to conversion from uterine fibroids to sarcoma of uterus .

  11. 本文还纯化了子宫肉瘤中性糖脂中主要的四糖基组分,应用HPTLC、酸解和酶解法以及特异单抗放射免疫染色法对该组分进行鉴定。

    One of the major components in leiomyosarcoma was purified and characterized by HPTLC , acid hydrolysis , glycosidase treatment and binding with specific McAbs on HPTLC plates .

  12. 结果:子宫肉瘤回声较紊乱,与子宫肌层分界不清,肿瘤表面及内部的血流阻力较低。

    The resistance of blood flow inside uterus sarcoma was lower .

  13. 子宫肉瘤的预后与临床分期、病理类型有明显关系。

    Prognosis is significantly associated with clinical stage , pathological type .

  14. 65例复发及转移的子宫肉瘤分析

    A clinical analysis of 65 uterine sarcomas with recurrence or metastasis

  15. 子宫肉瘤术后辅助治疗102例临床观察

    Clinical Study of Adjuvant Therapy in 102 Cases with Uterine Sarcoma

  16. 目的分析子宫肉瘤误诊的常见原因。

    Objective To analyze the causes of misdiagnosis of uterine sarcomas .

  17. 超声对子宫肉瘤诊断的初步探讨

    Tentative research on the ultrasonic diagnosis of sarcoma of uterus

  18. 子宫肉瘤106例临床及病理分析

    Clinical and pathological analysis on 106 cases with uterine sarcoma

  19. 目的:子宫肉瘤为少见的子宫恶性肿瘤。

    Objective : Uterine sarcoma is a kind of rare malignant tumor .

  20. 子宫肉瘤的超声检查

    The Value of Ultrasound in Detection of Uterus Sarcoma

  21. 子宫肉瘤及子宫肌瘤良性变的超声诊断

    Ultrasound diagnosis and differential diagnosis of uterine sarcoma and hysteromyoma in benign change

  22. 子宫肉瘤的超声检查巨噬细胞激活作用的研究

    The Value of Ultrasound in Detection of Uterus Sarcoma Studies on macrophage activation

  23. 子宫肉瘤预后的多因素分析

    Multivariate analysis of prognostic factors for uterine sarcoma

  24. 19例子宫肉瘤临床分析

    A Clinical analysis of 19 uterine sarcomas

  25. 子宫肉瘤细胞遗传学研究现状和进展

    Progresses in Cytogenetical Research of Uterus Sarcoma

  26. 目的探讨二维超声对子宫肉瘤的诊断价值。

    Try to explore the diagnostic evaluation of two dimensional ultrasonic on Sarcoma of uterus .

  27. 子宫肉瘤放射治疗的临床观察

    Radiotherapy in the treatment of uterine sarcomas

  28. 目的探讨子宫肉瘤术后及复发肿瘤联合化疗疗效。

    Objective To study the results of combination chemotherapy of uterine sarcoma after operation and recurrent tumor .

  29. 子宫肉瘤的联合化疗

    Combination chemotherapy of uterine sarcomas

  30. 1例26岁与子宫肉瘤相关的非产褥期子宫内翻患者:病例报道与文献回顾

    Non-puerperal uterine inversion in association with uterine sarcoma : Case report in a 26-year-old and review of the literature